Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pulsed Oral Sirolimus in ADPKD
NCT02055079Phase 3Unknown
- Sponsor
- Medical University of Vienna
- Start
- Apr 2014
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sirolimus in autosomal dominant polycystic kidney disease (ADPKD), sponsored by Medical University of Vienna. Status: unknown.
02
Drugs
sirolimus
03
Conditions
autosomal dominant polycystic kidney disease (ADPKD)
Beyond the preview
Go deeper on NCT02055079.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02055079.